319 related articles for article (PubMed ID: 31071486)
1. Atypical neuroleptic malignant syndrome - A case report.
Vellekkatt F; Kuppili PP; Bharadwaj B; Menon V
Asian J Psychiatr; 2019 Jun; 43():7-8. PubMed ID: 31071486
[TBL] [Abstract][Full Text] [Related]
2. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
Reeves RR; Mack JE; Torres RA
Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
[TBL] [Abstract][Full Text] [Related]
4. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
[TBL] [Abstract][Full Text] [Related]
5. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
[TBL] [Abstract][Full Text] [Related]
6. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome due to olanzapine.
Hall KL; Taylor WH; Ware MR
Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
[TBL] [Abstract][Full Text] [Related]
8. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
10. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
[TBL] [Abstract][Full Text] [Related]
11. Atypical neuroleptic malignant syndrome associated with olanzapine.
Reeves RR; Torres RA; Liberto V; Hart RH
Pharmacotherapy; 2002 May; 22(5):641-4. PubMed ID: 12013364
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Croarkin PE; Emslie GJ; Mayes TL
J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
Chungh DS; Kim BN; Cho SC
J Psychopharmacol; 2005 Jul; 19(4):422-5. PubMed ID: 15982999
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
[TBL] [Abstract][Full Text] [Related]
15. Risperidone-induced neuroleptic malignant syndrome.
Sharma R; Trappler B; Ng YK; Leeman CP
Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
Musselman ME; Browning LA; Parker D; Saely S
Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report.
Chang CK; Payus AO; Noh MM; Lansing MG; Sumpat D; Lu SJA; Yew BT
J Med Case Rep; 2022 Oct; 16(1):366. PubMed ID: 36203196
[TBL] [Abstract][Full Text] [Related]
18. Atypical neuroleptic malignant syndrome caused by olanzapine.
Nielsen J; Bruhn AM
Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
[TBL] [Abstract][Full Text] [Related]
19. [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol].
Marloth PV; Ladefoged MR; Boesen MS
Ugeskr Laeger; 2022 Nov; 184(45):. PubMed ID: 36345898
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine-associated neuroleptic malignant syndrome.
Norgard NB; Stark JE
Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]